APEX1 gene amplification and its protein overexpression in osteosarcoma

Correlation with recurrence, metastasis, and survival

Jilong Yang, Da Yang, David Cogdell, Xiaoling Du, Haixin Li, Yi Pang, Yan Sun, Limei Hu, Baocun Sun, Jonathan Trent, Kexin Chen, Wei Zhang

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The expression of apurinic/apyrimidinic exonuclease 1 (APEX1) in tumors has been linked with chemoresistance, radioresistance, and shorter patient survival times. We sought to gain insight into the role of APEX1 in human osteosarcoma by evaluation of gene copy number alterations and its protein expression in osteosarcoma patients treated at the Sarcoma Center of Tianjin Cancer Hospital (Tianjin, China). To evaluate the gene copy number alterations of APEX1, we acquired 10 fresh tissue samples from 9 patients and performed whole-genome array-based comparative genomic hybridization (aCGH). We next acquired formalin-fixed and paraffin embedded tissues from 57 well-annotated osteosarcoma cases and performed immunohistochemical analyses for APEX1. APEX1 gene amplification was observed in 50% (5/10) of the osteosarcoma samples. The overexpression of APEX1 protein was detected in 64.9% (37/57) of the osteosarcomas ranging from negative (35.1%, 20/57), weakly positive (35.1%, 20/57), moderate (14%, 8/57) and strongly positive (15.8%, 9/57). The APEX1 expression had significant correlation with osteosarcoma local recurrence and/or metastasis. Moreover, multivariate analysis showed that APEX1 expression was an independent molecular predictor for disease-free survival of patients with osteosarcomas. Our study for the first time showed that APEX1 gene was amplified in osteosarcomas and that APEX1 expression was an independent predictor of the osteosarcoma local recurrence and/or metastasis. Thus, APEX1 may serve as a prognostic marker and potential therapeutic target for osteosarcoma.

Original languageEnglish
Pages (from-to)161-169
Number of pages9
JournalTechnology in Cancer Research and Treatment
Volume9
Issue number2
StatePublished - Apr 1 2010
Externally publishedYes

Fingerprint

Gene Amplification
Osteosarcoma
Neoplasm Metastasis
Recurrence
Survival
Proteins
Gene Dosage
exodeoxyribonuclease I
Cancer Care Facilities
Comparative Genomic Hybridization
Sarcoma
Paraffin
Formaldehyde
Disease-Free Survival
China
Multivariate Analysis
Genome

Keywords

  • APEX1
  • Gene amplification
  • Osteosarcoma
  • Prognostic predictor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

APEX1 gene amplification and its protein overexpression in osteosarcoma : Correlation with recurrence, metastasis, and survival. / Yang, Jilong; Yang, Da; Cogdell, David; Du, Xiaoling; Li, Haixin; Pang, Yi; Sun, Yan; Hu, Limei; Sun, Baocun; Trent, Jonathan; Chen, Kexin; Zhang, Wei.

In: Technology in Cancer Research and Treatment, Vol. 9, No. 2, 01.04.2010, p. 161-169.

Research output: Contribution to journalArticle

Yang, J, Yang, D, Cogdell, D, Du, X, Li, H, Pang, Y, Sun, Y, Hu, L, Sun, B, Trent, J, Chen, K & Zhang, W 2010, 'APEX1 gene amplification and its protein overexpression in osteosarcoma: Correlation with recurrence, metastasis, and survival', Technology in Cancer Research and Treatment, vol. 9, no. 2, pp. 161-169.
Yang, Jilong ; Yang, Da ; Cogdell, David ; Du, Xiaoling ; Li, Haixin ; Pang, Yi ; Sun, Yan ; Hu, Limei ; Sun, Baocun ; Trent, Jonathan ; Chen, Kexin ; Zhang, Wei. / APEX1 gene amplification and its protein overexpression in osteosarcoma : Correlation with recurrence, metastasis, and survival. In: Technology in Cancer Research and Treatment. 2010 ; Vol. 9, No. 2. pp. 161-169.
@article{f0e6ff726a9947c7a67d15228a57dd77,
title = "APEX1 gene amplification and its protein overexpression in osteosarcoma: Correlation with recurrence, metastasis, and survival",
abstract = "The expression of apurinic/apyrimidinic exonuclease 1 (APEX1) in tumors has been linked with chemoresistance, radioresistance, and shorter patient survival times. We sought to gain insight into the role of APEX1 in human osteosarcoma by evaluation of gene copy number alterations and its protein expression in osteosarcoma patients treated at the Sarcoma Center of Tianjin Cancer Hospital (Tianjin, China). To evaluate the gene copy number alterations of APEX1, we acquired 10 fresh tissue samples from 9 patients and performed whole-genome array-based comparative genomic hybridization (aCGH). We next acquired formalin-fixed and paraffin embedded tissues from 57 well-annotated osteosarcoma cases and performed immunohistochemical analyses for APEX1. APEX1 gene amplification was observed in 50{\%} (5/10) of the osteosarcoma samples. The overexpression of APEX1 protein was detected in 64.9{\%} (37/57) of the osteosarcomas ranging from negative (35.1{\%}, 20/57), weakly positive (35.1{\%}, 20/57), moderate (14{\%}, 8/57) and strongly positive (15.8{\%}, 9/57). The APEX1 expression had significant correlation with osteosarcoma local recurrence and/or metastasis. Moreover, multivariate analysis showed that APEX1 expression was an independent molecular predictor for disease-free survival of patients with osteosarcomas. Our study for the first time showed that APEX1 gene was amplified in osteosarcomas and that APEX1 expression was an independent predictor of the osteosarcoma local recurrence and/or metastasis. Thus, APEX1 may serve as a prognostic marker and potential therapeutic target for osteosarcoma.",
keywords = "APEX1, Gene amplification, Osteosarcoma, Prognostic predictor",
author = "Jilong Yang and Da Yang and David Cogdell and Xiaoling Du and Haixin Li and Yi Pang and Yan Sun and Limei Hu and Baocun Sun and Jonathan Trent and Kexin Chen and Wei Zhang",
year = "2010",
month = "4",
day = "1",
language = "English",
volume = "9",
pages = "161--169",
journal = "Technology in Cancer Research and Treatment",
issn = "1533-0346",
publisher = "Adenine Press",
number = "2",

}

TY - JOUR

T1 - APEX1 gene amplification and its protein overexpression in osteosarcoma

T2 - Correlation with recurrence, metastasis, and survival

AU - Yang, Jilong

AU - Yang, Da

AU - Cogdell, David

AU - Du, Xiaoling

AU - Li, Haixin

AU - Pang, Yi

AU - Sun, Yan

AU - Hu, Limei

AU - Sun, Baocun

AU - Trent, Jonathan

AU - Chen, Kexin

AU - Zhang, Wei

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The expression of apurinic/apyrimidinic exonuclease 1 (APEX1) in tumors has been linked with chemoresistance, radioresistance, and shorter patient survival times. We sought to gain insight into the role of APEX1 in human osteosarcoma by evaluation of gene copy number alterations and its protein expression in osteosarcoma patients treated at the Sarcoma Center of Tianjin Cancer Hospital (Tianjin, China). To evaluate the gene copy number alterations of APEX1, we acquired 10 fresh tissue samples from 9 patients and performed whole-genome array-based comparative genomic hybridization (aCGH). We next acquired formalin-fixed and paraffin embedded tissues from 57 well-annotated osteosarcoma cases and performed immunohistochemical analyses for APEX1. APEX1 gene amplification was observed in 50% (5/10) of the osteosarcoma samples. The overexpression of APEX1 protein was detected in 64.9% (37/57) of the osteosarcomas ranging from negative (35.1%, 20/57), weakly positive (35.1%, 20/57), moderate (14%, 8/57) and strongly positive (15.8%, 9/57). The APEX1 expression had significant correlation with osteosarcoma local recurrence and/or metastasis. Moreover, multivariate analysis showed that APEX1 expression was an independent molecular predictor for disease-free survival of patients with osteosarcomas. Our study for the first time showed that APEX1 gene was amplified in osteosarcomas and that APEX1 expression was an independent predictor of the osteosarcoma local recurrence and/or metastasis. Thus, APEX1 may serve as a prognostic marker and potential therapeutic target for osteosarcoma.

AB - The expression of apurinic/apyrimidinic exonuclease 1 (APEX1) in tumors has been linked with chemoresistance, radioresistance, and shorter patient survival times. We sought to gain insight into the role of APEX1 in human osteosarcoma by evaluation of gene copy number alterations and its protein expression in osteosarcoma patients treated at the Sarcoma Center of Tianjin Cancer Hospital (Tianjin, China). To evaluate the gene copy number alterations of APEX1, we acquired 10 fresh tissue samples from 9 patients and performed whole-genome array-based comparative genomic hybridization (aCGH). We next acquired formalin-fixed and paraffin embedded tissues from 57 well-annotated osteosarcoma cases and performed immunohistochemical analyses for APEX1. APEX1 gene amplification was observed in 50% (5/10) of the osteosarcoma samples. The overexpression of APEX1 protein was detected in 64.9% (37/57) of the osteosarcomas ranging from negative (35.1%, 20/57), weakly positive (35.1%, 20/57), moderate (14%, 8/57) and strongly positive (15.8%, 9/57). The APEX1 expression had significant correlation with osteosarcoma local recurrence and/or metastasis. Moreover, multivariate analysis showed that APEX1 expression was an independent molecular predictor for disease-free survival of patients with osteosarcomas. Our study for the first time showed that APEX1 gene was amplified in osteosarcomas and that APEX1 expression was an independent predictor of the osteosarcoma local recurrence and/or metastasis. Thus, APEX1 may serve as a prognostic marker and potential therapeutic target for osteosarcoma.

KW - APEX1

KW - Gene amplification

KW - Osteosarcoma

KW - Prognostic predictor

UR - http://www.scopus.com/inward/record.url?scp=77952062040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952062040&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 161

EP - 169

JO - Technology in Cancer Research and Treatment

JF - Technology in Cancer Research and Treatment

SN - 1533-0346

IS - 2

ER -